Urdu Translation of Wayfinding Questionnaire for Stroke Patients

December 9, 2022 updated by: Riphah International University

Urdu Translation and Cross Cultural Validation of Wayfinding Questionnaire for Stroke Patients

Descriptive analytical study to translate WQ in Urdu Language. The WQ is in English Language the name of the author of WQ is Van der Ham Et al and firstly introduced in 2013. The reliability of this English tool is 0.70 to 0.80 it has been translated in various Languages i.e Hungarian, Dutch and Chinese and suffering from stroke. But it was not translated in Urdu Language. No such study has been previously conducted in Pakistan region which translates the scale and follows the proper cross-cultural adaptation

Study Overview

Status

Completed

Conditions

Detailed Description

For resolving such problem WQ play pivotal role in accessing navigation problem of stroke patients it is a very reliable tool for accessing navigation issue. The scale consists of 22 items. All the items dated from 01 to 07 in which stroke patients are accessed. The patients who are taken in the study age from 18 to 65 years. As the WQ is a well-developed measurement scale for accessing navigation in stroke patients. It is meaningful to validate its Urdu version. The translation and cultural adaptation process would start after obtaining approval from the developer of the original WQ. This would be done according to bitten guidelines. The purpose will be to gain uniformity in the translation of both the target Language and source Language. This will involve 5 steps which is forward translation, synthesis 1, back translation, synthesis 2 and pallet testing. The second step would be done according to the Beaton guidelines in which psychometric properties will be measured that is internal consistency, test retest reliability, Discriminant validity, Convergent Validity, Content Validity and Factor analysis

Study Type

Observational

Enrollment (Actual)

70

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Pakistan
    • Pakistan(Punjab_
      • Lahore, Pakistan(Punjab_, Pakistan, 54000
        • Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

45 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

stroke

Description

Inclusion Criteria:

  • Age group 45-65 years
  • Male and Female.
  • Both ischemic and hemorrhagic stroke
  • Patient may have First or Recurrent Stroke.
  • Recovery is > 6 months of First Stroke event
  • MMSE score > 25

Exclusion Criteria:

  • Population suffering from Severe Global Aphasia.
  • Population suffering from Severe Mobility Problem.
  • Any other neurological disease dementia
  • Alzheimer's
  • Cognitive Decline before Stroke

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Cross-Sectional

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Wayfinding Questionnaire
Time Frame: 8 months
For resolving such problem WQ play pivotal role in accessing navigation problem of stroke patients it is a very reliable tool for accessing navigation issue. The scale consists of 22 items. All the items rated from 1 to 7 in which stroke patients are assessed. The patients who are taken in the study age from 45 to 65 years.
8 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Reliability of translated version of WQ
Time Frame: 8 months

To determine the reliability of cross-culturally adapted and translated WQ in the patients with stroke.

Reliability or reproducibility reference to a measure to produce the same results when administered at to intervals between different visits of the patients. Thus this will be measured through test re-test reliability
8 months
Validity of translated version of WQ
Time Frame: 8 months
To determine the validity of cross-culturally adapted and translated WQ for stroke patients in Urdu language
8 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Riphah International University

Investigators

  • Principal Investigator: Tehreem Mukhtar, Riphah International University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 15, 2021

Primary Completion (Actual)

July 15, 2022

Study Completion (Actual)

July 30, 2022

Study Registration Dates

First Submitted

April 28, 2022

First Submitted That Met QC Criteria

May 10, 2022

First Posted (Actual)

May 16, 2022

Study Record Updates

Last Update Posted (Estimate)

December 12, 2022

Last Update Submitted That Met QC Criteria

December 9, 2022

Last Verified

December 1, 2022

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • REC/Lhr/22/0207 Suhair Asif

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Switzerland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe